Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:nabilone
|
| gptkbp:approvalYear |
1985
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:A04AD11
|
| gptkbp:chemicalFormula |
C24H36O3
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_II_(US)
|
| gptkbp:countryOfOperation |
gptkb:Canada
gptkb:United_States |
| gptkbp:drugClass |
Cannabis
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cesamet
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Meda_Pharmaceuticals
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
drowsiness euphoria dry mouth |
| gptkbp:synonym |
gptkb:nabilone
|
| gptkbp:usedFor |
chemotherapy-induced nausea and vomiting
|
| gptkbp:bfsParent |
gptkb:nabilone
|
| gptkbp:bfsLayer |
7
|